의료진
의료진소개
장민혜
- [진료과] 병리과
- [주연구분야] 심폐병리, 부인과병리, 유방병리
- [직위] 교수, 병리과 과장
- [진료과목] 심폐병리, 부인과병리
진료예약
| 의사 | 진료과목 | 구분 | 월 | 화 | 수 | 목 | 금 | 토 | 예약 |
|---|---|---|---|---|---|---|---|---|---|
| 장민혜 | 심폐병리, 부인과병리 | 오전 |
전화 예약 (620-4030) |
||||||
| 오후 |
경력
영남대학교 의과대학 졸업
서울대학교 대학원 박사
분당서울대학교 병원 임상강사
건국대학교병원 임상강사
서울대학교 대학원 박사
분당서울대학교 병원 임상강사
건국대학교병원 임상강사
학회 및 대외활동
1. FGFR1 is amplified during the progression of in situ to invasive breast carcinoma. Breast Cancer Res 2012
2. The Diagnostic Usefulness of HMGA2, Survivin, CEACAM6, and SFN/14-3-3 δ in Follicular Thyroid Carcinoma. J Pathol Transl Med. 2015
3. of epithelial-mesenchymal transition-related markers in triple-negative breast cancer: ZEB1 as a potential biomarker for poor clinical outcome. Hum Pathol 2015
4. Assessment of HER2 status in invasive breast cancers with increased centromere 17 copy number. Breast Cancer Res Treat. 2015
5. The of Carbonic Anhydrase (CA) IX/XII and Lymph Node stasis in Early Breast Cancer. Cancer Res Treat. 2016
6. Review of Medical Advisory Services by the Korean Society of Pathologists from 2003 to 2014. J Pathol Transl Med. 2016
2. The Diagnostic Usefulness of HMGA2, Survivin, CEACAM6, and SFN/14-3-3 δ in Follicular Thyroid Carcinoma. J Pathol Transl Med. 2015
3. of epithelial-mesenchymal transition-related markers in triple-negative breast cancer: ZEB1 as a potential biomarker for poor clinical outcome. Hum Pathol 2015
4. Assessment of HER2 status in invasive breast cancers with increased centromere 17 copy number. Breast Cancer Res Treat. 2015
5. The of Carbonic Anhydrase (CA) IX/XII and Lymph Node stasis in Early Breast Cancer. Cancer Res Treat. 2016
6. Review of Medical Advisory Services by the Korean Society of Pathologists from 2003 to 2014. J Pathol Transl Med. 2016